Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-25 @ 4:33 AM
Ignite Modification Date: 2025-12-25 @ 4:33 AM
NCT ID: NCT01552018
Eligibility Criteria: Inclusion Criteria: * Patients \> 18, \< 80 years old, with type 2 diabetes mellitus and angiographically proven coronary artery disease. * HbA1c \> 6.5% and under treatment with either metformin and/or glimepiride. Exclusion Criteria: * Allergy or hypersensitivity to any of the drug's components. * Heart failure in NYHA class III or IV. * Severe liver failure, moderate or severe kidney failure * Malignant disease. * Active infectious disease. * Acute coronary syndrome in the last 3 months. * Pregnancy or breastfeeding.
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Maximum Age: 80 Years
Study: NCT01552018
Study Brief:
Protocol Section: NCT01552018